Futura

Views & Analysis

Though PDE5 inhibitor drugs like Viagra have dominated the sexual health market for decades, the treatments come with some severe disadvantages.

News

AstraZeneca prepares to move its oral GLP-1 elecoglipron into phase 3 for obesity and diabetes, after reporting encouraging phase 2b data at ADA.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.